Mobia Medical, Inc MOBI
—
9.06
0.25
2.84%
as of 25 Sep
- Market cap
- $293.3M
- P/E
- 0.0×
Follow MOBI
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | 0.00 |
+2 more quarters Free account |
P/S ratio |
6.75 | 0.00 | — | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | — | 0.00 | |
P/Operating CF |
(16.32) | (0.61) | — | (0.61) | |
P/B ratio |
1.48 | 0.00 | — | 0.00 | |
Price to Tangible BV |
1.48 | 0.00 | — | 0.00 | |
EV/Sales |
2.27 | 0.00 | — | 0.00 | |
EV/EBITDA |
0.00 | 0.00 | — | 0.00 | |
EV/Operating CF |
(0.95) | (0.04) | — | (0.04) | |
EV/FCF |
(0.93) | (0.04) | — | (0.04) | |
Quick Ratio |
12.63 | 5.12 | 3.73 | — | |
Current Ratio |
13.28 | 6.06 | 4.54 | — | |
Net Debt/EBITDA |
9.56 | 0.46 | 0.00 | 0.00 | |
Debt/Assets |
3.73% | 65.20% | 14.81% | 0.00% | |
Debt/Equity |
0.04 | 3.99 | 0.25 | 0.00 | |
Asset Turnover |
0.39 | 0.00 | — | — | |
Operating CF/Net income |
0.74 | 1.00 | 0.00 | 1.05 | |
Capex/Depreciation |
(9.81) | (0.23) | (1.94) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
16.87% | 14.01% | — | 21.25% | |
Selling, General and Administrative Expense of Revenue |
199.08% | 208.60% | — | 217.74% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
11.90% | 3.37% | — | 6.05% | |
Graham Net Nets |
0.66 | 0.94 | — | 0.94 | |
Graham Number |
0.00 | 0.00 | — | 0.00 | |
Earnings Yield |
(341.88%) | (341.88%) | — | (341.88%) | |
Free Cash Flow Yield |
(35.98%) | (783.22%) | — | (783.22%) | |
Revenue per Share |
0.71 | 13.14 | — | 7.92 | |
Operating CF per Share |
(0.82) | (19.29) | 0.00 | (13.05) | |
Capex per Share |
(0.08) | (0.05) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.90) | (19.34) | 0.00 | (13.05) | |
Cash per Share |
9.28 | 60.64 | 0.00 | 0.00 | |
Shareholders Equity per Share |
9.04 | 13.08 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.04 | 13.08 | 0.00 | 0.00 | |
Free Cash Flow |
(17.21) | (17.77) | (46.06) | (11.00) | |
Working Capital |
177.68 | 59.88 | 36.15 | — | |
Capital Expenditures |
(1.54) | (0.04) | (0.36) | 0.00 | |
Net Current Asset Value |
169.47 | 10.14 | 27.21 | 0.00 | |
EV/EBIT |
0.00 | 0.00 | — | 0.00 | |
Capex to Sales |
0.11 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(155.82%) | (146.93%) | — | (157.18%) | |
Price to Operating Income |
0.00 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Assets |
97.64 | 47.84 | — | — |
Columns are period end dates